254 related articles for article (PubMed ID: 16255672)
1. Therapeutic applications of carbon monoxide-releasing molecules.
Motterlini R; Mann BE; Foresti R
Expert Opin Investig Drugs; 2005 Nov; 14(11):1305-18. PubMed ID: 16255672
[TBL] [Abstract][Full Text] [Related]
2. CORM-A1: a new pharmacologically active carbon monoxide-releasing molecule.
Motterlini R; Sawle P; Hammad J; Bains S; Alberto R; Foresti R; Green CJ
FASEB J; 2005 Feb; 19(2):284-6. PubMed ID: 15556971
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic potential of carbon monoxide in multiple sclerosis.
Fagone P; Mangano K; Coco M; Perciavalle V; Garotta G; Romao CC; Nicoletti F
Clin Exp Immunol; 2012 Feb; 167(2):179-87. PubMed ID: 22235993
[TBL] [Abstract][Full Text] [Related]
4. Positive inotropic effects of carbon monoxide-releasing molecules (CO-RMs) in the isolated perfused rat heart.
Musameh MD; Fuller BJ; Mann BE; Green CJ; Motterlini R
Br J Pharmacol; 2006 Dec; 149(8):1104-12. PubMed ID: 17057755
[TBL] [Abstract][Full Text] [Related]
5. Cerebroprotective effects of the CO-releasing molecule CORM-A1 against seizure-induced neonatal vascular injury.
Zimmermann A; Leffler CW; Tcheranova D; Fedinec AL; Parfenova H
Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2501-7. PubMed ID: 17630349
[TBL] [Abstract][Full Text] [Related]
6. Antithrombotic properties of water-soluble carbon monoxide-releasing molecules.
Kramkowski K; Leszczynska A; Mogielnicki A; Chlopicki S; Fedorowicz A; Grochal E; Mann B; Brzoska T; Urano T; Motterlini R; Buczko W
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2149-57. PubMed ID: 22772756
[TBL] [Abstract][Full Text] [Related]
7. Carbon monoxide-releasing molecule-A1 inhibits Th1/Th17 and stimulates Th2 differentiation in vitro.
Nikolic I; Vujicic M; Stojanovic I; Stosic-Grujicic S; Saksida T
Scand J Immunol; 2014 Aug; 80(2):95-100. PubMed ID: 24845722
[TBL] [Abstract][Full Text] [Related]
8. Carbon monoxide and its donors - their implications for medicine.
Adach W; Olas B
Future Med Chem; 2019 Jan; 11(1):61-73. PubMed ID: 30526059
[TBL] [Abstract][Full Text] [Related]
9. Carbon monoxide-releasing molecules (CO-RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophages.
Sawle P; Foresti R; Mann BE; Johnson TR; Green CJ; Motterlini R
Br J Pharmacol; 2005 Jul; 145(6):800-10. PubMed ID: 15880142
[TBL] [Abstract][Full Text] [Related]
10. Carbon monoxide-releasing molecules: a pharmacological expedient to counteract inflammation.
Alcaraz MJ; Guillen MI; Ferrandiz ML; Megías J; Motterlini R
Curr Pharm Des; 2008; 14(5):465-72. PubMed ID: 18289073
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of platelet aggregation by carbon monoxide-releasing molecules (CO-RMs): comparison with NO donors.
Chlopicki S; Lomnicka M; Fedorowicz A; Grochal E; Kramkowski K; Mogielnicki A; Buczko W; Motterlini R
Naunyn Schmiedebergs Arch Pharmacol; 2012 Jun; 385(6):641-50. PubMed ID: 22362133
[TBL] [Abstract][Full Text] [Related]
12. Water-soluble carbon monoxide-releasing molecules: helping to elucidate the vascular activity of the 'silent killer'.
Chatterjee PK
Br J Pharmacol; 2004 Jun; 142(3):391-3. PubMed ID: 15148242
[TBL] [Abstract][Full Text] [Related]
13. The effects of carbon monoxide releasing molecules on paraquat-induced pulmonary interstitial inflammation and fibrosis.
Huang KC; Li JC; Wang SM; Cheng CH; Yeh CH; Lin LS; Chiu HY; Chang CY; Chuu JJ
Toxicology; 2021 May; 456():152750. PubMed ID: 33737140
[TBL] [Abstract][Full Text] [Related]
14. Astrocyte-produced carbon monoxide and the carbon monoxide donor CORM-A1 protect against cerebrovascular dysfunction caused by prolonged neonatal asphyxia.
Parfenova H; Pourcyrous M; Fedinec AL; Liu J; Basuroy S; Leffler CW
Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H978-H988. PubMed ID: 30028198
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effects of carbon monoxide-releasing molecules on post-ischemic myocardial recovery.
Varadi J; Lekli I; Juhasz B; Bacskay I; Szabo G; Gesztelyi R; Szendrei L; Varga E; Bak I; Foresti R; Motterlini R; Tosaki A
Life Sci; 2007 Apr; 80(17):1619-26. PubMed ID: 17321552
[TBL] [Abstract][Full Text] [Related]
16. Heme is required for carbon monoxide activation of mitochondrial BK
Rotko D; Bednarczyk P; Koprowski P; Kunz WS; Szewczyk A; Kulawiak B
Eur J Pharmacol; 2020 Aug; 881():173191. PubMed ID: 32422186
[TBL] [Abstract][Full Text] [Related]
17. Bioactive properties of iron-containing carbon monoxide-releasing molecules.
Sawle P; Hammad J; Fairlamb IJ; Moulton B; O'Brien CT; Lynam JM; Duhme-Klair AK; Foresti R; Motterlini R
J Pharmacol Exp Ther; 2006 Jul; 318(1):403-10. PubMed ID: 16603670
[TBL] [Abstract][Full Text] [Related]
18. Carbon monoxide released by CORM-A1 prevents yeast cell death via autophagy stimulation.
Figueiredo-Pereira C; Menezes R; Ferreira S; Santos CN; Vieira HLA
FEMS Yeast Res; 2019 Aug; 19(5):. PubMed ID: 31344236
[TBL] [Abstract][Full Text] [Related]
19. Carbon Monoxide Releasing Molecule A1 Reduces Myocardial Damage After Acute Myocardial Infarction in a Porcine Model.
Iqbal J; Chamberlain J; Alfaidi M; Hughes M; Alizadeh T; Casbolt H; Evans P; Mann B; Motterlini R; Francis S; Gunn J
J Cardiovasc Pharmacol; 2021 Nov; 78(5):e656-e661. PubMed ID: 34328710
[TBL] [Abstract][Full Text] [Related]
20. Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule.
Clark JE; Naughton P; Shurey S; Green CJ; Johnson TR; Mann BE; Foresti R; Motterlini R
Circ Res; 2003 Jul; 93(2):e2-8. PubMed ID: 12842916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
